Anavex Life Sciences Corp (AVXL)

[xodcode]

Needham presentation was brilliant and complete.

Lot's of new news expected in the months immediately ahead.

Brought me back to Bio's "Disease Z" thesis whereby AZ, ADD and RTT, although manifesting uniquely, may well result from a common cause: misfolding of proteins and resulting destruction of autophagy process.

"A2-73 is an upstream multi-pathway process, (as opposed to a one-pathway approach of other (failed?) BigPharma approaches) which activates SIGMAR-1 which then helps the body to "heal thyself" via of repairing protein misfolding, promoting homeostasis and healthy autophagy.

Just imagine the AVXL increased following, if Bio's thesis ultimately proves to have merit and AVXL's upstream application of A2-73 is successful in aiding in the fight against neurological and neurodegenerative disease.

All AVXL publicly released information to date does point to a successful outcome of AVXL's A2-73's upstream approach to "DISEASE Z".